Search Results - "Armatys, Anna"
-
1
A hybrid protocol CLAG-M, a possible player for the first-line therapy of patients with mixed phenotype acute leukemia. A Polish Adult Leukemia Group experience
Published in Frontiers in oncology (21-05-2024)“…Mixed-phenotype acute leukemia (MPAL) is a rare disease with poor prognosis. So far, no standard approach has been established as the "know-how" of MPAL is…”
Get full text
Journal Article -
2
Real Life Data on Efficacy and Safety of Azacitidine Therapy for Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia
Published in Pathology oncology research (01-07-2019)“…The administration of azacitidine (AZA) was found to be more effective than conventional care regimen (CCR) in patients with higher-risk myelodysplastic…”
Get full text
Journal Article -
3
Allogeneic hematopoietic stem cell transplantation remains a feasible approach for elderly with acute myeloid leukemia: a 10-year experience
Published in Annals of hematology (01-07-2023)“…The incidence of AML increases with age. The implementation of reduced intensity conditioning and progress in supportive care enabled to perform allo-HSCT in…”
Get full text
Journal Article -
4
-
5
Impact of Cytoreductive Drugs upon Outcomes in a Contemporary Cohort of Adolescent and Young Adults with Essential Thrombocythemia and Polycythemia Vera
Published in Blood (02-11-2023)“…Introduction Essential thrombocythemia (ET) and polycythemia vera (PV) are well described in adolescent and young adults (AYA) patients (pts); the most…”
Get full text
Journal Article -
6
Ruxolitinib for steroid-refractory acute graft versus host disease: case series and literature review
Published in Acta haematologica polonica (25-02-2022)Get full text
Journal Article -
7
Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: A Single-Centre Experience
Published in Clinical lymphoma, myeloma and leukemia (01-01-2023)“…Patients with relapsed/refractory acute myeloid leukemia (r/r AML) are characterized as having a poor prognosis. The only viable option of treatment for these…”
Get full text
Journal Article -
8
Allogeneic stem cell transplantation remains an effective therapeutic approach for patients with therapy-related acute myeloid leukemia
Published in Acta haematologica polonica (29-04-2021)Get full text
Journal Article -
9
Myeloproliferative Neoplasms in Patients below 25 Years Old at Diagnosis: A Retrospective International Cooperative Work
Published in Blood (29-11-2018)“…Myeloproliferative neoplasms (MPN) are most common in old people (>60 years) and are rarely identified in children and young adults where information about…”
Get full text
Journal Article -
10
Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs
Published in Blood advances (13-09-2022)“…Myeloproliferative neoplasms (MPNs) are uncommon in children/young adults. Here, we present data on unselected patients diagnosed before 25 years of age…”
Get full text
Journal Article -
11
-
12
Outcome of a Real-Life Population of Patients With Acute Promyelocytic Leukemia Treated According to the PETHEMA Guidelines: The Polish Adult Leukemia Group (PALG) Experience
Published in Clinical lymphoma, myeloma and leukemia (01-02-2020)“…Acute promyelocytic leukemia (APL) has a favorable prognosis. However, results of randomized studies do not necessarily reflect the outcomes of a real-life…”
Get full text
Journal Article -
13
The outcome of primary mediastinal B-cell lymphoma in a single center experience
Published in Acta haematologica polonica (01-01-2015)“…Primary mediastinal B-cell lymphoma (PMBCL) is an aggressive distinct subtype of diffuse large B-cell lymphoma (DLBCL). There is no standard treatment for…”
Get full text
Journal Article -
14
Autologous stem cell transplantation for mantle cell lymphoma - single centre experience
Published in Contemporary oncology (Poznan, Poland) (2013)“…Mantle cell lymphoma (MCL) is a B-cell neoplasm showing resistance to conventional chemotherapy. High-dose chemotherapy followed by autologous stem cell…”
Get full text
Journal Article